MX2013012230A - Composiciones nutricionales que tienen a-hica y citrulina y metodos para utilizar las mismas. - Google Patents
Composiciones nutricionales que tienen a-hica y citrulina y metodos para utilizar las mismas.Info
- Publication number
- MX2013012230A MX2013012230A MX2013012230A MX2013012230A MX2013012230A MX 2013012230 A MX2013012230 A MX 2013012230A MX 2013012230 A MX2013012230 A MX 2013012230A MX 2013012230 A MX2013012230 A MX 2013012230A MX 2013012230 A MX2013012230 A MX 2013012230A
- Authority
- MX
- Mexico
- Prior art keywords
- nutritional compositions
- citrulline
- methods
- nutritional
- same
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 235000016709 nutrition Nutrition 0.000 title abstract 5
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 title abstract 2
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 title abstract 2
- 235000013477 citrulline Nutrition 0.000 title abstract 2
- 229960002173 citrulline Drugs 0.000 title abstract 2
- 102000008934 Muscle Proteins Human genes 0.000 abstract 2
- 108010074084 Muscle Proteins Proteins 0.000 abstract 2
- 108010046377 Whey Proteins Proteins 0.000 abstract 2
- 102000007544 Whey Proteins Human genes 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 235000021119 whey protein Nutrition 0.000 abstract 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 1
- 208000036119 Frailty Diseases 0.000 abstract 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 206010003549 asthenia Diseases 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 239000000693 micelle Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 235000013406 prebiotics Nutrition 0.000 abstract 1
- 238000001243 protein synthesis Methods 0.000 abstract 1
- 208000001076 sarcopenia Diseases 0.000 abstract 1
- 230000014616 translation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E10/00—Energy generation through renewable energy sources
- Y02E10/70—Wind energy
- Y02E10/72—Wind turbines with rotation axis in wind direction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Pediatric Medicine (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
Abstract
Se proporcionan las composiciones nutricionales para maximizar la síntesis de proteína muscular y minimizar el catabolismo de las proteínas musculares y métodos para utilizar las mismas. En esta forma, las composiciones nutricionales pueden proporcionar la retención de la masa corporal magra, que ayuda a evitar la pérdida de independencia y funcionalidad, así como a mejorar ¡a calidad de vida en especial en los ancianos en riesgo de sarcopenia y fragilidad. Las composiciones nutricionales incluyen ácido a-hidroxi-isocaproico y citrulina. La composición puede incluir otros ingredientes funcionales tales como, pero no limitados a proteína de suero de leche, que incluye micelas de proteína de suero de leche, fibras prebióticas, a-cetoglutarato, ácido eicosapentaenoico, L-carnitina, nucleótidos, y aminoácidos. También se proporcionan métodos para administrar tales composiciones nutricionales a los individuos que necesiten de las mismas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161476345P | 2011-04-18 | 2011-04-18 | |
PCT/EP2012/057093 WO2012143403A1 (en) | 2011-04-18 | 2012-04-18 | Nutritional compositions having alpha-hica and citrulline |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2013012230A true MX2013012230A (es) | 2014-06-05 |
Family
ID=45976400
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013012231A MX2013012231A (es) | 2011-04-18 | 2012-04-18 | Composiciones nutricionales que tienen a-hica y a-cetoglutarato y metodos para utilizar las mismas. |
MX2013012228A MX2013012228A (es) | 2011-04-18 | 2012-04-18 | Composiciones nutricionales que tienen a-hica y metodos para utilizar las mismas. |
MX2013012230A MX2013012230A (es) | 2011-04-18 | 2012-04-18 | Composiciones nutricionales que tienen a-hica y citrulina y metodos para utilizar las mismas. |
MX2013012229A MX2013012229A (es) | 2011-04-18 | 2013-10-18 | Composiciones nutricionales que tienen a-hica y acido eicosapentaenoico y metodos para utilizar las mismas. |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013012231A MX2013012231A (es) | 2011-04-18 | 2012-04-18 | Composiciones nutricionales que tienen a-hica y a-cetoglutarato y metodos para utilizar las mismas. |
MX2013012228A MX2013012228A (es) | 2011-04-18 | 2012-04-18 | Composiciones nutricionales que tienen a-hica y metodos para utilizar las mismas. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013012229A MX2013012229A (es) | 2011-04-18 | 2013-10-18 | Composiciones nutricionales que tienen a-hica y acido eicosapentaenoico y metodos para utilizar las mismas. |
Country Status (13)
Country | Link |
---|---|
US (4) | US20140056862A1 (es) |
EP (4) | EP2699113A1 (es) |
JP (4) | JP2014512372A (es) |
CN (4) | CN103458710A (es) |
AU (4) | AU2012244749A1 (es) |
BR (2) | BR112013026706A2 (es) |
CA (4) | CA2832507A1 (es) |
MX (4) | MX2013012231A (es) |
PH (1) | PH12013502027A1 (es) |
RU (4) | RU2013151085A (es) |
SG (4) | SG194028A1 (es) |
WO (4) | WO2012143404A1 (es) |
ZA (4) | ZA201308604B (es) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2583566E (pt) * | 2011-10-21 | 2015-11-13 | Nestec Sa | Micelas de proteína de soro de leite para aumentar a massa muscular e desempenho |
EP2583563A1 (en) * | 2011-10-21 | 2013-04-24 | Nestec S.A. | Whey protein micelles against muscle atrophy and sarcopenia |
ITBO20120226A1 (it) * | 2012-04-24 | 2013-10-25 | Alfa Wassermann Spa | Composizioni comprendenti ornitina alfa-chetoglutarato, processi per il loro ottenimento e il loro uso. |
CN103783532B (zh) * | 2012-10-29 | 2016-06-08 | 杭州纽曲星生物科技有限公司 | 一种抗老年性肌肉衰减的复合蛋白质粉及其制备方法 |
BR112015025490B1 (pt) * | 2013-04-15 | 2022-05-03 | Société des Produits Nestlé S.A. | Uso de uma fonte de aminoácidos em combinação com o estímulo muscular elétrico |
CN112931879A (zh) * | 2013-06-10 | 2021-06-11 | N·V·努特里奇亚 | 超重或肥胖成年人在体重减轻项目期间的肌肉保持 |
CN107223020A (zh) * | 2013-09-25 | 2017-09-29 | 胺细拉健康公司 | 用于预防和治疗糖尿病和肥胖症的组合物和制剂及其产生和用于葡萄糖和卡路里控制的方法 |
AU2014333977B2 (en) * | 2013-10-09 | 2019-12-19 | Société des Produits Nestlé S.A. | Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome |
CN103637212B (zh) * | 2013-12-13 | 2014-12-24 | 广东省农业科学院蚕业与农产品加工研究所 | 一种具有降血脂作用的管饲临床营养品及其制备方法 |
CN106061479B (zh) * | 2014-03-07 | 2019-04-23 | 味之素株式会社 | 虚弱预防剂 |
JPWO2015137387A1 (ja) * | 2014-03-11 | 2017-04-06 | 協和発酵バイオ株式会社 | 筋肉増強剤 |
EP3128859A1 (en) * | 2014-03-26 | 2017-02-15 | Abbott Laboratories | Nutritional supplement powder |
US20190054093A1 (en) * | 2014-04-04 | 2019-02-21 | Nektium Pharma Sl | Treatment of sarcopenia with ecdysteroids |
WO2015160262A1 (en) * | 2014-04-16 | 2015-10-22 | Amerikal Nutraceutical Corp | Anti-aging composition |
CN104027340B (zh) * | 2014-05-14 | 2018-08-24 | 田芳 | 一种含有三水合乳果糖组合物的可溶性粉剂及其制备方法 |
US20170196243A1 (en) * | 2014-06-03 | 2017-07-13 | Abbott Laboratories | Potato based protein mixtures and nutritional compositions comprising potato protein |
US11102994B2 (en) | 2014-08-21 | 2021-08-31 | Clearfast Inc. | Pre-operative carbohydrate-rich beverage composition and methods of treatment |
WO2016044167A1 (en) * | 2014-09-15 | 2016-03-24 | Abbott Laboratories | Methods for increasing muscle strength and mobility in subjects experiencing significant physical inactivity using gamma linolenic acid |
ES2960218T3 (es) * | 2014-10-14 | 2024-03-01 | Nestle Sa | Mejora en la funcionalidad del músculo de hombres ancianos |
US11040022B2 (en) * | 2015-02-05 | 2021-06-22 | William H. Cross, III | Compositions and methods for pain relief |
NL2015032B1 (en) * | 2015-06-26 | 2017-01-24 | Vitalnext B V | Compositions and methods for the treatment of malnutrition. |
WO2017075289A1 (en) | 2015-10-27 | 2017-05-04 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
RU2614881C1 (ru) * | 2015-12-29 | 2017-03-30 | Общество с ограниченной ответственностью "Мобильный доктор" | Комплекс биологически активных веществ, защищающих спортсменов от перетренированности |
WO2017114686A1 (en) * | 2015-12-30 | 2017-07-06 | Nestec S.A. | Method for determining fat free body mass |
CN108697139A (zh) | 2016-02-29 | 2018-10-23 | 雅培制药有限公司 | 营养补充粉 |
US11612632B2 (en) | 2017-04-25 | 2023-03-28 | William H. Cross, III | Compositions and methods for treatment of prediabetes |
NZ746681A (en) * | 2016-05-20 | 2022-07-01 | Nestle Sa | Nutritional compositions for cardiac protection in companion animals |
CN106213522A (zh) * | 2016-08-05 | 2016-12-14 | 郑家福 | 营养保健品 |
RU2635373C1 (ru) * | 2016-08-25 | 2017-11-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" | Биологически активная добавка для повышения общей работоспособности |
CN109803673A (zh) | 2016-09-13 | 2019-05-24 | 阿勒根公司 | 非蛋白质梭菌毒素组合物 |
AU2017361804B2 (en) * | 2016-11-16 | 2021-09-09 | Fresenius Kabi Deutschland Gmbh | Nutritional composition for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
KR20180081361A (ko) * | 2017-01-06 | 2018-07-16 | 연세대학교 산학협력단 | 인돌-3-카비놀 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 근육 질환 예방 또는 치료용 조성물 |
EP3615029A4 (en) | 2017-04-25 | 2021-04-21 | Buck Institute for Research on Aging | FORMULATIONS TO EXTEND LIFE AND HEALTH LIFETIME |
EP3641566A1 (en) | 2017-06-21 | 2020-04-29 | Abbott Laboratories | Methods for increasing growth of beneficial bacteria in the gastrointestinal tract |
CN107242572A (zh) * | 2017-07-06 | 2017-10-13 | 广州彤博士健康科技有限公司 | 营养补充剂及制备方法 |
WO2019036471A1 (en) | 2017-08-14 | 2019-02-21 | Axcella Health Inc. | AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE |
CN107616505B (zh) * | 2017-10-24 | 2020-12-25 | 精晶药业股份有限公司 | 一种含有鸟氨酸酮戊二酸的保健品及其制备方法 |
PL238310B1 (pl) * | 2017-10-31 | 2021-08-09 | Top Energy Set Spolka Z Ograniczona Odpowiedzialnoscia | Preparat leczniczy oraz sposób jego uzyskiwania |
US11304971B2 (en) | 2018-01-31 | 2022-04-19 | William H. Cross, III | Metformin compositions and methods for treatment of diabetes |
US11154523B2 (en) | 2018-01-31 | 2021-10-26 | William H. Cross, III | Compositions and methods for treatment of diabetic neuropathies |
US11351188B2 (en) | 2018-01-31 | 2022-06-07 | William H. Cross, III | Folic compositions and methods for treatment of diabetic neuropathies |
AR115585A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo |
JP2022502489A (ja) | 2018-09-25 | 2022-01-11 | ポンス デ レオン ヘルス デジグネイテッド アクティビティ カンパニー | αケトグルタル酸カルシウムを製造するためのプロセス |
WO2020106746A1 (en) * | 2018-11-19 | 2020-05-28 | Heh Research & Development Services, Inc. | Biologic enhancement formulation |
KR102171518B1 (ko) * | 2019-02-21 | 2020-10-29 | 한양대학교 에리카산학협력단 | 지골피 추출물을 유효성분으로 함유하는 근 위축 예방 또는 치료용 조성물 |
MX2021013777A (es) * | 2019-05-31 | 2021-12-10 | Nestle Sa | Mezcla nutricional a base de mct para proporcionar beneficios para la salud en animales. |
WO2020252005A1 (en) * | 2019-06-10 | 2020-12-17 | Buck Institute For Research On Aging | Methods and compositions for altering senescence associated secretory phenotype |
CN110226756A (zh) * | 2019-06-18 | 2019-09-13 | 山东理工大学 | 预防和缓解2型糖尿病患者肌少症的蛋白组件及制备方法 |
TWI774966B (zh) * | 2019-06-25 | 2022-08-21 | 生合生物科技股份有限公司 | 胚芽乳桿菌bcrc 910734用於提升老年個體的肌力以及治療肌肉減少症的用途 |
US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
US20210196772A1 (en) * | 2019-12-27 | 2021-07-01 | Grove Collaborative, Inc. | Confections for skin protection: compositions, methods for making, and applications thereof |
MX2022011963A (es) * | 2020-03-30 | 2022-10-20 | Gervais Danone Sa | Composiciones de leche fermentada para su uso en metodos de suplementacion nutricional. |
FI129515B (en) * | 2020-11-06 | 2022-03-31 | Salarusta Oy | FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY |
CN112899204B (zh) * | 2021-03-19 | 2022-06-28 | 杭州百芮生物科技有限公司 | 一种益生菌冻干外壳复合保护剂及其应用 |
CN113398144B (zh) * | 2021-07-27 | 2022-04-01 | 陈玉松 | 核苷酸混合物在制备预防或缓解老年肌少症制剂中的应用 |
CN114029085B (zh) * | 2021-12-06 | 2024-02-27 | 中触媒新材料股份有限公司 | 一种烯烃环氧化催化剂及其制备方法和应用 |
WO2023121696A1 (en) * | 2021-12-20 | 2023-06-29 | Schneider Todd C | Formulation and treatment for extended micronutrient therapy |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2335215B2 (de) * | 1972-07-13 | 1979-04-05 | The Johns Hopkins University, Baltimore, Md. (V.St.A.) | Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen |
GB1442154A (en) * | 1973-04-30 | 1976-07-07 | Walser M | Composition for promotion of protein synthesis and suppression of urea formation in the body |
GB1444621A (en) * | 1973-04-30 | 1976-08-04 | Walser M | Composition for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy-acid analogues of amino acids |
GB1511302A (en) * | 1974-04-15 | 1978-05-17 | Univ Johns Hopkins | Pharmaceutical compositions comprising amino acid analogues |
US4752619A (en) | 1985-12-23 | 1988-06-21 | The Johns Hopkins University | Nutritional supplement for treatment of uremia |
SE8803144L (sv) * | 1988-09-07 | 1990-03-08 | Kabivitrum Ab | Energisubstrat |
SE9201584D0 (sv) * | 1992-05-20 | 1992-05-20 | Vinnars Erik Ab | Use of alpha-ketoglutarate |
US5646187A (en) * | 1992-05-20 | 1997-07-08 | Ab Erik Vinnars | Use of alpha-ketoglutarate |
SE0201713D0 (sv) * | 2001-11-23 | 2002-06-06 | Gramineer Internat Ab | New methods and use III |
US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
US8795693B2 (en) * | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
WO2005107735A2 (en) * | 2004-04-30 | 2005-11-17 | Pump Formulations, Ltd. | Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, incresing nutrient delivery and/or promoting increased vascular response in a |
FI20045395A (fi) * | 2004-10-21 | 2006-04-22 | Elmomed Ltd Oy | Ravintoainelisä ja sen käyttö |
WO2007082914A2 (en) * | 2006-01-19 | 2007-07-26 | Entress Ab | Method of diagnosis and method of treatment |
WO2006127936A2 (en) * | 2005-05-23 | 2006-11-30 | Cadbury Adams Usa Llc | Taste potentiator compositions and edible confectionery and chewing gum products containing same |
CN101179943B (zh) * | 2005-05-23 | 2013-06-26 | 卡夫食品环球品牌有限责任公司 | 填充液体的咀嚼型胶基糖组合物 |
EP1774973A1 (en) * | 2005-10-12 | 2007-04-18 | Nutricia N.V. | Leucine rich composition |
CA2628265A1 (en) * | 2005-11-08 | 2007-05-18 | Multi Formulations Ltd. | The use of compositions comprising ketoacids and amino acids for increasing muscle mass and muscle performance |
DE602006008985D1 (de) * | 2005-12-16 | 2009-10-15 | Nutricia Nv | Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund |
AU2006338839A1 (en) * | 2006-02-23 | 2007-08-30 | Iomedix Sleep International Srl | Compositions and methods for the induction and maintenance of quality sleep |
MX2008012072A (es) * | 2006-03-23 | 2008-11-25 | Nestec Sa | Suplemento nutricional alto en calorias. |
EP2612666A3 (en) * | 2006-04-04 | 2013-10-02 | Nestec S.A. | Treatments using citrulline |
CN101415414B (zh) * | 2006-04-04 | 2013-06-12 | 雀巢产品技术援助有限公司 | 瓜氨酸在制备治疗矫正脓毒症患者中精氨酸缺乏的药物中的用途 |
PL379512A1 (pl) * | 2006-04-21 | 2007-10-29 | Sgp & Sons Ab | Nowe metody i ich zastosowanie |
AR062305A1 (es) * | 2006-08-09 | 2008-10-29 | Iams Company | Metodos para mejorar la salud osea y la salud muscular |
FR2913885B1 (fr) * | 2007-03-22 | 2012-07-20 | Univ Paris Descartes | Utilisation de la citrulline pour le traitement des pathologies liees a une augmentation de la carbonylation des proteines |
AU2007358961A1 (en) * | 2007-09-11 | 2009-03-19 | Northern Innovations And Formulations Corp. | Composition and method for increasing the anabolic state of muscle cells |
CA2610820A1 (en) * | 2007-12-12 | 2008-12-29 | Michele Molino | Method for maintaining physiological ph levels during intensive physical exercise |
US20090156647A1 (en) * | 2007-12-12 | 2009-06-18 | Iovate T. & P. Inc. | Method for maintaining physiological pH levels during intensive physical exercise |
WO2010002242A1 (en) * | 2008-07-02 | 2010-01-07 | N.V. Nutricia | Nutritional composition for improving muscle function and daily activity |
JP2010105946A (ja) * | 2008-10-29 | 2010-05-13 | Nof Corp | 筋タンパク質増強剤及びこれを含む医薬品または食品 |
WO2010108016A2 (en) * | 2009-03-18 | 2010-09-23 | Healthspan Solutions, Llc | Compositions and methods for sparing muscle in renal insufficiency and during hemodialysis |
WO2010137944A1 (en) * | 2009-05-27 | 2010-12-02 | N.V. Nutricia | Treatment of hypercalcaemia |
CN102647990A (zh) * | 2009-07-20 | 2012-08-22 | 雀巢产品技术援助有限公司 | 减少功能状态损失的方法 |
CN102481009A (zh) * | 2009-08-13 | 2012-05-30 | 雀巢产品技术援助有限公司 | 包含外源性核苷酸的营养组合物 |
BR112012005783A2 (pt) * | 2009-09-14 | 2017-05-30 | Nestec Sa | composições nutricionais incluindo vitamina k2 exógena |
-
2012
- 2012-04-18 RU RU2013151085/13A patent/RU2013151085A/ru not_active Application Discontinuation
- 2012-04-18 AU AU2012244749A patent/AU2012244749A1/en not_active Abandoned
- 2012-04-18 US US14/112,746 patent/US20140056862A1/en not_active Abandoned
- 2012-04-18 WO PCT/EP2012/057094 patent/WO2012143404A1/en active Application Filing
- 2012-04-18 MX MX2013012231A patent/MX2013012231A/es unknown
- 2012-04-18 CA CA2832507A patent/CA2832507A1/en not_active Abandoned
- 2012-04-18 WO PCT/EP2012/057095 patent/WO2012143405A1/en active Application Filing
- 2012-04-18 CA CA2831001A patent/CA2831001A1/en not_active Abandoned
- 2012-04-18 BR BR112013026706A patent/BR112013026706A2/pt not_active IP Right Cessation
- 2012-04-18 BR BR112013026539A patent/BR112013026539A2/pt not_active IP Right Cessation
- 2012-04-18 JP JP2014505605A patent/JP2014512372A/ja active Pending
- 2012-04-18 CA CA2832150A patent/CA2832150A1/en not_active Abandoned
- 2012-04-18 JP JP2014505604A patent/JP2014512371A/ja active Pending
- 2012-04-18 WO PCT/EP2012/057093 patent/WO2012143403A1/en active Application Filing
- 2012-04-18 SG SG2013073465A patent/SG194028A1/en unknown
- 2012-04-18 CN CN2012800179097A patent/CN103458710A/zh active Pending
- 2012-04-18 EP EP12719308.4A patent/EP2699113A1/en not_active Withdrawn
- 2012-04-18 EP EP12719307.6A patent/EP2699112A1/en not_active Withdrawn
- 2012-04-18 US US14/112,779 patent/US20140056863A1/en not_active Abandoned
- 2012-04-18 AU AU2012244750A patent/AU2012244750A1/en not_active Abandoned
- 2012-04-18 WO PCT/EP2012/057092 patent/WO2012143402A1/en active Application Filing
- 2012-04-18 RU RU2013151083/13A patent/RU2013151083A/ru not_active Application Discontinuation
- 2012-04-18 JP JP2014505603A patent/JP2014519483A/ja active Pending
- 2012-04-18 EP EP12715104.1A patent/EP2699110A1/en not_active Withdrawn
- 2012-04-18 CA CA2831165A patent/CA2831165A1/en not_active Abandoned
- 2012-04-18 MX MX2013012228A patent/MX2013012228A/es unknown
- 2012-04-18 MX MX2013012230A patent/MX2013012230A/es unknown
- 2012-04-18 RU RU2013151090/13A patent/RU2013151090A/ru not_active Application Discontinuation
- 2012-04-18 EP EP12718133.7A patent/EP2699111A1/en not_active Withdrawn
- 2012-04-18 CN CN201280019059.4A patent/CN103491804A/zh active Pending
- 2012-04-18 CN CN2012800190607A patent/CN103476275A/zh active Pending
- 2012-04-18 SG SG2013073986A patent/SG194065A1/en unknown
- 2012-04-18 JP JP2014505606A patent/JP2014511890A/ja active Pending
- 2012-04-18 SG SG2013071386A patent/SG193933A1/en unknown
- 2012-04-18 SG SG2013071626A patent/SG193938A1/en unknown
- 2012-04-18 CN CN2012800190556A patent/CN103476274A/zh active Pending
- 2012-04-18 AU AU2012244748A patent/AU2012244748B2/en not_active Ceased
- 2012-04-18 US US14/112,785 patent/US20140044685A1/en not_active Abandoned
- 2012-04-18 AU AU2012244751A patent/AU2012244751A1/en not_active Abandoned
- 2012-04-18 US US14/112,744 patent/US20140037604A1/en not_active Abandoned
- 2012-04-18 RU RU2013151087/13A patent/RU2013151087A/ru not_active Application Discontinuation
-
2013
- 2013-09-30 PH PH12013502027A patent/PH12013502027A1/en unknown
- 2013-10-18 MX MX2013012229A patent/MX2013012229A/es not_active Application Discontinuation
- 2013-11-15 ZA ZA2013/08604A patent/ZA201308604B/en unknown
- 2013-11-15 ZA ZA2013/08606A patent/ZA201308606B/en unknown
- 2013-11-15 ZA ZA2013/08605A patent/ZA201308605B/en unknown
- 2013-11-15 ZA ZA2013/08607A patent/ZA201308607B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013012230A (es) | Composiciones nutricionales que tienen a-hica y citrulina y metodos para utilizar las mismas. | |
PH12019500644A1 (en) | Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections | |
WO2017058892A3 (en) | Methods and compositions for antibody-evading virus vectors | |
BR112013026114A2 (pt) | composições nutricionais que incluem ácidos graxos de cadeia ramificada e processos de utilização das mesmas | |
CY1118601T1 (el) | Αλκυλαμινο-υποκατεστημενες δικυανοπυριδινες και προφαρμακα τυπου εστερα αμινοξεος αυτων | |
MX370852B (es) | Sal (es) de dimetil-amida del ácido 7-ciclopentil-2- (5-piperazin-1-il-piridin-2-il-amino) -7h-pirrolo- [2, 3-d]-pirimidin-6-carboxílico y procesos para su elaboración. | |
FI20115156L (fi) | Maitopohjainen tuote ja menetelmä sen valmistamiseksi | |
WO2013002584A3 (ko) | 다중 타겟팅의 상승 효과를 유발하는 유효물질의 조합 및 그 용도 | |
EA201491212A1 (ru) | Увлажняющая композиция, включающая аминопептидную смесь | |
UA107571C2 (xx) | Фармацевтична композиція | |
MX2014011459A (es) | Proteinas nutritivas cargadas y metodos. | |
EA201070419A1 (ru) | Состав для регулирования метаболизма липидов | |
NZ606250A (en) | Methods of inhibition of protein fucosylation in vivo using fucose analogs | |
NZ700686A (en) | Uses of casein compositions | |
MX342257B (es) | Derivados y análogos de oxaspiro [2.5] octano. | |
BR112014008700A2 (pt) | composições úteis no tratamento de nefropatia e processos para preparação das mesmas | |
RU2015122497A (ru) | Содержащие лактоферрин питательные композиции на основе молока и их применение | |
MY161390A (en) | Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations | |
BR112014009265A2 (pt) | micelas de proteína de soro do leite contra atrofia muscular e sarcopenia | |
MX353777B (es) | Composiciones nutricionales de suero-caseina parcialmente hidrolizadas para reducir la aparicion de alergias. | |
WO2018068947A3 (de) | Proteinhydrolysate | |
EA201590601A1 (ru) | Применение pedf-производных полипептидов для лечения остеоартрита | |
WO2011121607A3 (en) | Rasagiline and its pharmaceutically acceptable salts | |
GB2510712A (en) | Nutritional product comprising a biguanide | |
WO2010057275A8 (en) | Cyclic peptides and uses thereof |